Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential

TSX:EDT - Post by User

Spectral Medical Inc > Kellum Kudos

<< Previous

Bullboard Posts

Next >>

Comment by Gorf79on Jul 26, 2022 12:12pm

224 Views

Post# 34851236

RE:RE:Kellum Kudos

The Sepsis campaign of today's release is not a reach out to investors.

It is a compliment to the Vincenza show where PMX is introduced to the medical community at large and nephrologists in general.

Beyond the obligatory requirement to inform investors, it is all about preparing doctors and clinicians for the PMX launch!!!

It's coming sooner than 99% of our 40 or less retail investors expect!

<< Previous

Bullboard Posts

Next >>

Advancing an underexplored area of the Yukon with the same geology as B.C’.s Golden Triangle